Top Penny
1 month ago
Otsuka
On February 25, 2024, the Company entered into the PD-1 Purchase Agreement with Otsuka pursuant to which the Company sold and assigned to Otsuka, and Otsuka purchased and assumed, all intellectual property rights directly related to the Companyβs PD-1 Assets developed or held for development. The Company received an upfront payment of $1.0 million in cash at closing which is reported as a gain in the fiscal year ended June 30, 2024. The Company will also be eligible to receive additional contingent cash payments totaling up to $52.5 million upon the achievement of certain pre-specified clinical development and commercial milestones. The Company will recognize the potential milestone payments at the earlier of when the contingent consideration is realized or is realizable.
Affiliates of Eastern Capital Limited
On November 1, 2021, the Company and its subsidiary, iBio CDMO LLC (βiBio CDMOβ, and collectively with the Company, the βPurchaserβ) entered into a series of agreements (the βTransactionβ) with College Station Investors LLC (βCollege Stationβ), and Bryan Capital Investors LLC (βBryan Capitalβ and, collectively with College Station, βSellerβ), each affiliates of Eastern Capital Limited (βEastern,β a former significant stockholder of the Company) described in more detail below whereby in exchange for a certain cash payment and a warrant the Company:
(i) acquired both the Facility where iBio CDMO at that time and currently conducts business and also the rights as the tenant in the Facilityβs ground lease;
(ii) acquired all of the equity owned by one of the affiliates of Eastern in the Company and iBio CDMO; and
(iii) otherwise terminated all agreements between the Company and the affiliates of Eastern.
The Facility is a life sciences building located on land owned by the Board of Regents of the Texas A&M University System (βTexas A&Mβ) and is designed and equipped for the manufacture of plant-made biopharmaceuticals. iBio CDMO had held a sublease for the Facility through 2050, subject to extension until 2060 (the βSubleaseβ) until the consummation of the sale of the Facility.
redspeed
7 months ago
Toast...
"We are filing this registration statement with the Securities and Exchange Commission (the βSECβ) using a βshelfβ registration process. Under this registered βshelf,β in the future, we may, from time to time, sell any combination of the securities described herein, in one or more offerings, up to a maximum aggregate offering price of $150,000,000. This prospectus provides you with a general description of the securities."
redspeed
10 months ago
Prolly should have mentioned of the 21 funds holding IBIO and 251,464 shares, Sabby Management has the majority of those at 176,748
https://www.holdingschannel.com/bystock/?symbol=IBIO
Shabby is a known short and SEC charged them with Naked Shorting. Oh what a surprise financial advisors getting charged.
SEC Charges Investment Adviser and Principal in Abusive Naked Short Selling Scheme - June 12, 2023
https://www.sec.gov/news/press-release/2023-107
It seems after they were charged, they started buying the stocks they 'apparently' shorted. Maybe a way to hedge their 'SEC charges' bets?
Basically subtract out Sabby, there are very little shares held by 'tutes' anymore. Maybe not as smittened by iBio's new CEO Dr. Martin Brenner?
https://fintel.io/i/sabby-management-llc
https://hedgefollow.com/funds/Sabby+Management
JPetroInc
10 months ago
hey thanks for thinking of me being important enough to dox me brah
yeah Tom Isett - old news pal - sorry to inform yhee
need to keep up with the changing times Sporto
let me help you with that - here's some educatin from iBio's new CEO Dr. Martin Brenner:
Part 1
Part 2
https://www.google.com/search?q=The+biotech+podcast+Martin+Brenner+Ibio+part+2&sca_esv=6470011d51d3dd33&hl=en&ei=i07yZdvEEbGi5NoP0J2z0AE&ved=0ahUKEwibtvP3yPKEAxUxEVkFHdDODBoQ4dUDCBA&uact=5&oq=The+biotech+podcast+Martin+Brenner+Ibio+part+2&gs_lp=Egxnd3Mtd2l6LXNlcnAiLlRoZSBiaW90ZWNoIHBvZGNhc3QgTWFydGluIEJyZW5uZXIgSWJpbyBwYXJ0IDIyBRAhGKABMgUQIRigAUiCEFCIC1inDHABeACQAQCYAbABoAGSAqoBAzEuMbgBA8gBAPgBAZgCAqACowLCAggQABiABBiiBJgDAIgGAZIHAzAuMqAHxQQ&sclient=gws-wiz-serp#fpstate=ive&vld=cid:93919661,vid:CHMoWpWRtlg,st:0
Part 3
https://www.google.com/search?q=The+biotech+podcast+Martin+Brenner+Ibio+part+3&sca_esv=6470011d51d3dd33&hl=en&ei=-07yZbaUCbKt5NoP05aLwAo&ved=0ahUKEwj2_Z6tyfKEAxWyFlkFHVPLAqgQ4dUDCBA&uact=5&oq=The+biotech+podcast+Martin+Brenner+Ibio+part+3&gs_lp=Egxnd3Mtd2l6LXNlcnAiLlRoZSBiaW90ZWNoIHBvZGNhc3QgTWFydGluIEJyZW5uZXIgSWJpbyBwYXJ0IDMyBRAhGKABSN0RUPINWOgOcAF4AJABAJgBvQGgAa0CqgEDMC4yuAEDyAEA-AEBmAICoAK1ApgDAIgGAZIHAzAuMqAHsQU&sclient=gws-wiz-serp#fpstate=ive&vld=cid:b0c180ba,vid:oXXUaw4yX2c,st:0
after that, you can watch old Turner Classic movie's with that fake purple heart companion
all weekend long for that matter
but not until you get through Part 3 - OK sporto...?
cheers mate and OooRah iBio to you
MOO dyslexic